Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults.

Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, Haniffa M, Diamond EL, Durham BH, Visser J, Hunt D, Gunawardena H, Macheta M, McClain KL, Allen C, Abdel-Wahab O, Collin M.

Blood. 2017 May 16. pii: blood-2016-12-757823. doi: 10.1182/blood-2016-12-757823. [Epub ahead of print]

PMID:
28512190
2.

Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.

Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Townsend RR, Chen X, Carr SA, Ellis MJ, Ding L.

Nat Commun. 2017 Apr 25;8:15479. doi: 10.1038/ncomms15479. No abstract available.

3.

Neurological Manifestations of IgG4-Related Disease.

Baptista B, Casian A, Gunawardena H, D'Cruz D, Rice CM.

Curr Treat Options Neurol. 2017 Apr;19(4):14. doi: 10.1007/s11940-017-0450-9. Review.

4.

Row versus column correlations: avoiding the ecological fallacy in RNA/protein expression studies.

O'Brien JJ, Gunawardena HP, Qaqish BF.

Brief Bioinform. 2017 Mar 26. doi: 10.1093/bib/bbx021. [Epub ahead of print]

PMID:
28369202
5.

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.

Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Reid Townsend R, Chen X, Carr SA, Ellis MJ, Ding L.

Nat Commun. 2017 Mar 28;8:14864. doi: 10.1038/ncomms14864.

6.

Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis.

Baumer T, Fry C, Luppe S, Gunawardena H, Sieradzan K.

J Neurovirol. 2017 Jun;23(3):508-510. doi: 10.1007/s13365-017-0517-0. Epub 2017 Feb 21.

PMID:
28224486
7.

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirják L, Distler JH, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Jobanputra P, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2017 Feb 10. pii: annrheumdis-2016-210503. doi: 10.1136/annrheumdis-2016-210503. [Epub ahead of print]

8.

Comment on: Rituximab in autoimmune connective tissue disease-associated interstitial lung disease: reply.

Sharp C, Gunawardena H.

Rheumatology (Oxford). 2016 Dec;55(12):2280-2281. Epub 2016 Aug 21. No abstract available.

PMID:
27550300
9.

Rituximab in autoimmune connective tissue disease-associated interstitial lung disease.

Sharp C, McCabe M, Dodds N, Edey A, Mayers L, Adamali H, Millar AB, Gunawardena H.

Rheumatology (Oxford). 2016 Jul;55(7):1318-24. doi: 10.1093/rheumatology/kew195. Epub 2016 Apr 8.

PMID:
27060110
10.

Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts.

Tabb DL, Wang X, Carr SA, Clauser KR, Mertins P, Chambers MC, Holman JD, Wang J, Zhang B, Zimmerman LJ, Chen X, Gunawardena HP, Davies SR, Ellis MJ, Li S, Townsend RR, Boja ES, Ketchum KA, Kinsinger CR, Mesri M, Rodriguez H, Liu T, Kim S, McDermott JE, Payne SH, Petyuk VA, Rodland KD, Smith RD, Yang F, Chan DW, Zhang B, Zhang H, Zhang Z, Zhou JY, Liebler DC.

J Proteome Res. 2016 Mar 4;15(3):691-706. doi: 10.1021/acs.jproteome.5b00859. Epub 2015 Dec 22.

11.

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.

Ruggles KV, Tang Z, Wang X, Grover H, Askenazi M, Teubl J, Cao S, McLellan MD, Clauser KR, Tabb DL, Mertins P, Slebos R, Erdmann-Gilmore P, Li S, Gunawardena HP, Xie L, Liu T, Zhou JY, Sun S, Hoadley KA, Perou CM, Chen X, Davies SR, Maher CA, Kinsinger CR, Rodland KD, Zhang H, Zhang Z, Ding L, Townsend RR, Rodriguez H, Chan D, Smith RD, Liebler DC, Carr SA, Payne S, Ellis MJ, Fenyő D.

Mol Cell Proteomics. 2016 Mar;15(3):1060-71. doi: 10.1074/mcp.M115.056226. Epub 2015 Dec 2.

12.

QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues.

Gunawardena HP, O'Brien J, Wrobel JA, Xie L, Davies SR, Li S, Ellis MJ, Qaqish BF, Chen X.

Mol Cell Proteomics. 2016 Feb;15(2):740-51. doi: 10.1074/mcp.O115.049791. Epub 2015 Nov 23.

13.

The Clinical Features of Myositis-Associated Autoantibodies: a Review.

Gunawardena H.

Clin Rev Allergy Immunol. 2017 Feb;52(1):45-57. doi: 10.1007/s12016-015-8513-8. Review.

PMID:
26453338
14.

Label-free Quantitative Proteomics Reveals a Role for the Mycobacterium tuberculosis SecA2 Pathway in Exporting Solute Binding Proteins and Mce Transporters to the Cell Wall.

Feltcher ME, Gunawardena HP, Zulauf KE, Malik S, Griffin JE, Sassetti CM, Chen X, Braunstein M.

Mol Cell Proteomics. 2015 Jun;14(6):1501-16. doi: 10.1074/mcp.M114.044685. Epub 2015 Mar 26.

15.

The role of biologics in treatment of connective tissue disease-associated interstitial lung disease.

Sharp C, Dodds N, Mayers L, Millar AB, Gunawardena H, Adamali H.

QJM. 2015 Sep;108(9):683-8. doi: 10.1093/qjmed/hcv007. Epub 2015 Jan 21. Review.

PMID:
25614613
16.

A chromatin activity-based chemoproteomic approach reveals a transcriptional repressome for gene-specific silencing.

Liu C, Yu Y, Liu F, Wei X, Wrobel JA, Gunawardena HP, Zhou L, Jin J, Chen X.

Nat Commun. 2014 Dec 15;5:5733. doi: 10.1038/ncomms6733.

17.

Differentially charged isoforms of apolipoprotein E from human blood are potential biomarkers of Alzheimer's disease.

Alzate O, Osorio C, DeKroon RM, Corcimaru A, Gunawardena HP.

Alzheimers Res Ther. 2014 Jul 14;6(4):43. doi: 10.1186/alzrt273. eCollection 2014.

18.

Redox regulation of Rac1 by thiol oxidation.

Hobbs GA, Mitchell LE, Arrington ME, Gunawardena HP, DeCristo MJ, Loeser RF, Chen X, Cox AD, Campbell SL.

Free Radic Biol Med. 2015 Feb;79:237-50. doi: 10.1016/j.freeradbiomed.2014.09.027. Epub 2014 Oct 5.

19.

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.

Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C, Arnold K, Yasin S, Moraitis E, Wedderburn LR, McHugh NJ; UK Juvenile Dermatomyositis Research Group..

Arthritis Res Ther. 2014 Jul 2;16(4):R138. doi: 10.1186/ar4600.

20.

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.

Tansley SL, Betteridge ZE, Shaddick G, Gunawardena H, Arnold K, Wedderburn LR, McHugh NJ; Juvenile Dermatomyositis Research Group..

Rheumatology (Oxford). 2014 Dec;53(12):2204-8. doi: 10.1093/rheumatology/keu259. Epub 2014 Jul 1.

Supplemental Content

Loading ...
Support Center